Literature DB >> 27087706

Preparation of tetrasubstituted pyrimido[4,5-d]pyrimidine diones.

Hui Wang1, Chao Wang1, Thomas D Bannister1.   

Abstract

A novel synthetic route to 1,3,5,7-tetrasubstituted pyrimido[4,5-d]pyrimidine-2,4-diones, of interest for potential antitumor activity, is reported. The route uses 1,3-disubstituted 6-amino uracils as starting materials. The key step is a hydrazine-induced cyclization reaction to form the fused pyrimidine ring. By choosing different uracils, acylation reagents and alkylation reagents, substituents at N-1, N-3, C-5, and C-7 may be selectively varied to provide a structurally diverse set of compounds for biological evaluation.

Entities:  

Keywords:  antitumor; heterocycles; inhibitor; pyrimidopyrimidines; synthesis

Year:  2015        PMID: 27087706      PMCID: PMC4829973          DOI: 10.1016/j.tetlet.2015.02.051

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  10 in total

1.  Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents.

Authors:  Pratibha Sharma; Nilesh Rane; V K Gurram
Journal:  Bioorg Med Chem Lett       Date:  2004-08-16       Impact factor: 2.823

2.  Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compounds.

Authors:  S D Guile; J R Bantick; D R Cheshire; M E Cooper; A M Davis; D K Donald; R Evans; C Eyssade; D D Ferguson; S Hill; R Hutchinson; A H Ingall; L P Kingston; I Martin; B P Martin; R T Mohammed; C Murray; M W D Perry; R H Reynolds; P V Thorne; D J Wilkinson; J Withnall
Journal:  Bioorg Med Chem Lett       Date:  2006-02-07       Impact factor: 2.823

3.  Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties.

Authors:  Simon D Guile; John R Bantick; Martin E Cooper; David K Donald; Christine Eyssade; Anthony H Ingall; Richard J Lewis; Barrie P Martin; Rukhsana T Mohammed; Timothy J Potter; Rachel H Reynolds; Stephen A St-Gallay; Andrew D Wright
Journal:  J Med Chem       Date:  2007-01-25       Impact factor: 7.446

4.  Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents.

Authors:  Samir M El-Moghazy; Diaa A Ibrahim; Nagwa M Abdelgawad; Nahla A H Farag; Ahmad S El-Khouly
Journal:  Sci Pharm       Date:  2011-05-08

5.  Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.

Authors:  A Chris Krueger; Darold L Madigan; David W Beno; David A Betebenner; Robert Carrick; Brian E Green; Wenping He; Dachun Liu; Clarence J Maring; Keith F McDaniel; Hongmei Mo; Akhteruzzaman Molla; Christopher E Motter; Tami J Pilot-Matias; Michael D Tufano; Dale J Kempf
Journal:  Bioorg Med Chem Lett       Date:  2012-02-02       Impact factor: 2.823

6.  Synthesis and evaluation of antimicrobial activity of novel hydrazino and N-benzylidinehydrazino-substituted 4,8-dihydro-1H,3H-pyrimido[4,5-d]pyrimidin-2,7-dithiones.

Authors:  Pratibha Sharma; Nilesh Rane; Priti Pandey
Journal:  Arch Pharm (Weinheim)       Date:  2006-10       Impact factor: 3.751

7.  Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.

Authors:  Joanne R Doherty; Chunying Yang; Kristen E N Scott; Michael D Cameron; Mohammad Fallahi; Weimin Li; Mark A Hall; Antonio L Amelio; Jitendra K Mishra; Fangzheng Li; Mariola Tortosa; Heide Marika Genau; Robert J Rounbehler; Yunqi Lu; Chi V Dang; K Ganesh Kumar; Andrew A Butler; Thomas D Bannister; Andrea T Hooper; Keziban Unsal-Kacmaz; William R Roush; John L Cleveland
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

8.  The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse.

Authors:  Valquiria Bueno; Isabelle Binet; Ulrich Steger; Robert Bundick; Douglas Ferguson; Clare Murray; David Donald; Kathryn Wood
Journal:  Transplantation       Date:  2007-11-15       Impact factor: 4.939

9.  Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors.

Authors:  Hui Wang; Chunying Yang; Joanne R Doherty; William R Roush; John L Cleveland; Thomas D Bannister
Journal:  J Med Chem       Date:  2014-08-22       Impact factor: 7.446

10.  AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.

Authors:  Matthew J Ovens; Andrew J Davies; Marieangela C Wilson; Clare M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-01-15       Impact factor: 3.857

  10 in total
  2 in total

Review 1.  Bicyclic 6 + 6 systems: the chemistry of pyrimido[4,5-d]pyrimidines and pyrimido[5,4-d]pyrimidines.

Authors:  M Monier; Doaa Abdel-Latif; Ahmed El-Mekabaty; Khaled M Elattar
Journal:  RSC Adv       Date:  2019-09-30       Impact factor: 4.036

2.  TBHP-mediated oxidative synthesis of substituted pyrimido[4,5-d]pyrimidines from N-uracil amidines and methylarenes under metal free conditions.

Authors:  Pradip Debnath
Journal:  RSC Adv       Date:  2019-09-20       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.